Skip to main content

J. Goldman & Co LP

Position in LRMR — Larimar Therapeutics, Inc.

CIK 1412741 NEW YORK, NY

Position in LRMR

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$151,902
-$2,403 QoQ
Shares Held
33,756
-16.7% QoQ
Ownership
0.032%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2020
12 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in LRMR Over Time

Shares Held

Position Value (USD)

Derivatives in LRMR

reported options exposure · as of Sep 30, 2025
CallValue
$436,050
CallShares
135,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

J. Goldman & Co LP holds $186,196,918 across 52 Biotechnology names. LRMR ranks #50 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in LRMR

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $151,902 33,756
2025-12-31 $154,305 40,500
2025-09-30 $658,028 203,724
2025-09-30 $436,050 135,000
2024-09-30 $129,067 19,705
2024-06-30 $142,861 19,705
2024-03-31 $212,520 28,000
2023-12-31 $254,991 56,042
2023-12-31 $213,850 47,000
2023-12-31 $82,355 18,100
2023-09-30 $213,300 54,000
2023-06-30 $169,020 54,000
2023-03-31 $550,395 121,500
2021-03-31 $167,153 11,441
2020-12-31 $1,548,885 72,344